| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |